Peisker A, Raschke GF, Schultze-Mosgau S. Management
of dental extraction in patients with Haemophilia A
and B: A report of 58 extractions. Med Oral Patol
Oral Cir Bucal. 2014 Jan 1;19 (1):e55-60.
doi:10.4317/medoral.19191
http://dx.doi.org/doi:10.4317/medoral.19191
|
1. Skinner
MW. Treatment for all: a vision for the future. Haemophilia.
2006;12:169-173. |
|
|
|
|
|
2. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003; 361:1801-1809. |
|
|
|
|
|
3. White
GC 2nd, Rosendaal F, Aledort
LM, Lusher JM, Rothschild C, Ingerslev
J. Factor VIII and Factor IX Subcommittee. Definitions in hemophilia.
Recommendation of the scientific subcommittee on factor VIII and factor IX of
the scientific and standardization committee of the International Society on
Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560. |
|
|
|
|
|
4. Hermans C, Altisent C, Batorova A, Chambost H, De Moerloose P, Karafoulidou A, et
al. European Haemophilia Therapy Standardisation Board. Replacement therapy for invasive
procedures in patients with haemophilia: literature
review, European survey and recommendations. Haemophilia. 2009;15:639-58. |
|
|
|
|
|
5. Stubbs
M, Lloyd J. A protocol for the dental management of von Willebrand's
disease, Haemophilia A and Haemophilia
B. Aust Dent J. 2001;46:37-40. |
|
|
|
|
|
6. Zanon E, Brandolin B, Saggiorato G, Bacci C. Complex
dental extractions in a patient with severe Haemophilia
A and inhibitors treated with activated prothrombin
complex concentrate. Blood Transfus. 2012;10:225-7. |
|
|
|
|
|
7. Hewson ID, Makhmaloaf P.
Management of third molar removal with a single dose of recombinant Factor IX
(BeneFIX) and local measures in severe Haemophilia B. Aust Dent J.
2010;55:322-4. |
|
|
|
|
|
8. Björkman S, Berntorp E.
Pharmacokinetics of coagulation factors: clinical relevance for patients with
haemophilia. Clin Pharmacokinet.
2001;40:815-32. |
|
|
|
|
|
9. Poon MC, Lillicrap D, Hensman C, Card R, Scully MF. Recombinant FIX recovery
and inhibitor safety: a Canadian post-licensure surveillance study. Thrombosis and Hemostasis. 2002;87:431-5. |
|
|
|
|
|
10. Srivastava A, Brewer AK, Mauser-Bunschoten
EP, Key NS, Kitchen S, Llinas A, et al. Treatment
Guidelines Working Group on Behalf of The World Federation Of Hemophilia.
Guidelines for the management of hemophilia. Haemophilia.
2013;19:1-47. |
|
|
|
|
|
11. Sultan
Y. Prevalence of inhibitors in a population of 3435 hemophilia patients in
France. Thromb Haemost. 1992;67:600-2. |
|
|
|
|
|
12. Hay
CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Wasseem N, et al. Factor VIII inhibitors in mild and
moderate severity haemophilia A. Thromb Haemost. 1998;79:762-6. |
|
|
|
|
|
13. Schwaab R, Brackmann HH, Meyer
C, Seehafer J, Kirchgesser
M, Haack A, et al. Haemophilia
A: Mutation type determines risk of inhibitor formation. Thromb
Haemost. 1995;74:1402-6. |
|
|
|
|
|
14. Addiego J, Kasper C, Abildgaard
C, Hilgartner M, Lusher
J, Glader B, et al. Frequency of inhibitor
development in haemophiliacs treated with
low-purity factor VIII. Lancet. 1993;342:462-4. |
|
|
|
|
|
15. Hay
CR, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC, et al. HLA class II profile: Aweak determinant of factor VIII inhibitor development in
severe haemophilia A. Thromb
Haemost. 1997;77:234-7. |
|
|
|
|
|
16.
Oldenburg J, Picard JK, Schwaab R, Brackmann HH, Tuddenham EG,
Simpson E. HLA genotype of patients with severe haemophilia
A due to intron 22 inversion with and without
inhibitors to factor VIII. Thromb Haemost. 1997;77:238-242. |
|
|
|
|
|
17.
O'Connell N, Mc Mahon C, Smith J, Khair K, Hann I, Liesner R, et al.
Recombinant factor VIIa in the management of
surgery and acute bleeding episodes in children with haemophilia
and high responding inhibitors. Br J Haematol. 2002;116:632-5. |
|
|
|
|
|
18. Mannucci PM. Desmopressin
(DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997;90:2515-21. |
|
|
|
|
|
19. Franchini M, Zaffanello M,
Lippi G. The use of desmopressin in mild hemophilia
A. Blood Coagul Fibrinolysis.
2010;21:615-9. |
|
|
|
|
|
20. Castaman G. Desmopressin for
the treatment of haemophilia. Haemophilia.
2008;14 Suppl 1:15-20. |
|
|
|
|
|
21. Piot B, Sigaud-Fiks M, Huet P, Fressinaud E, Trossaërt M, Mercier. Management of dental extractions in
patients with bleeding disorders. Oral Surg Oral
Med Oral Pathol Oral Radiol
Endod. 2002;93:247-50. |
|
|
|
|
|
22. Frachon X, Pommereuil M, Berthier AM, Lejeune S, Hourdin-Eude S, Quéro J, et al.
Management options for dental extraction in hemophiliacs: a study of 55
extractions (2000–2002). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:270-5. |
|
|
|
|
|
23. Srivastava A, Brewer AK, Mauser-Bunschoten
EP, Key NS, Kitchen S, Llinas A, et al. Guidelines
for the management of hemophilia. Haemophilia. 2013;19:1-47. |
|
|
|
|
|
24. Franchini M, Rossetti G, Tagliaferri
A, Pattacini C, Pozzoli
D, Lorenz C, et al. Dental procedures in adult
patients with hereditary bleeding disorders: 10 years experience in three
Italian Hemophilia Centers. Haemophilia. 2005;11:504-9. |
|
|
|
|
|
25. Rayen R, Hariharan VS, Elavazhagan N, Kamalendran N, Varadarajan R. Dental management of hemophiliac child under
general anesthesia. J Indian Soc Pedod Prev Dent. 2011;29:74-9. |
|
|
|
|
|
26. Kim
JC, Choi SS, Wang SJ, Kim SG. Minor complications
after mandibular third molar surgery: type,
incidence, and possible prevention. Oral Surg Oral
Med Oral Pathol Oral Radiol
Endod. 2006;102:4-11. |
|
|
|
|
|
27.
Jackson MR, McPhee MJ, Drohan
WN, Alving BM. Fibrin sealant: current and
potential clinical applications. Blood Coagul Fibrinolysis. 1996;7:737-46. |
|
|
|
|
|
28. Al-Belasy
FA, Amer MZ. Hemostatic effect of
n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery. J Oral Maxillofac Surg.
2003;61:1405-9. |
|
|
|
|
|
29. Wagner
WR, Pachence JM, Ristich
J, Johnson PC. Comparative in vitro analysis of topical hemostatic
agents. J Surg Res. 1996;66:100-108. |
|
|
|
|
|
30. Zanon E, Martinelli F, Bacci C, Zerbinati P, Girolami A. Proposal of a standard approach to dental
extraction in haemophilia patients. A case-control
study with good results. Haemophilia. 2000;6:533-6. |
|